Oral antivirals access opens to more Aboriginal Australians The move will come in with PBS changes from 1 November, which also include a treatment for a rare genetic disease.
Enhanced antivirals access a victory for patients RACGP Vice President Dr Bruce Willett goes behind the scenes of a successful campaign to help GPs supply oral antivirals to at-risk patients.
How scrapped iso requirements impact telehealth The end of COVID isolation also means fewer exemptions to the 12-month telehealth rule.
In Practice: Recognition for antiviral rollout GPs have been thanked by Australia’s Chief Medical Officer for spearheading the rollout of COVID-19 antiviral treatments.
Push to educate CALD patients on available COVID treatments While vaccination rates are rising among CALD populations, GPs should also focus on improving antiviral uptake for those eligible, an expert says.
Push to allow pharmacist prescribing of antivirals flipped on its head A ‘more sensible approach’ would see the lifesaving medications added to the Doctor’s Bag, a prominent GP has said.
Could anticipatory deprescribing allow better COVID treatment? Despite being more effective according to some studies, Paxlovid prescriptions lag Lagevrio, with drug–drug interactions likely to play a part.
Clarity over longer telehealth phone consultations The new item numbers will be available from Tuesday 19 July, but GPs will not be able to claim for services already delivered.
Doctors and pharmacists in united call to continue subsidised COVID tests The COVID-19 Rapid Test Concessional Access Program will not be extended beyond the end of July, despite the ongoing BA.5 wave.
Expanded COVID antivirals access hindered by telehealth restrictions While more people are now eligible to receive treatment through the PBS, GPs warn that vulnerable patients risk being left behind due to a lack of MBS support for extended phone consultations.